Rapilysin Den europeiske union - norsk - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - reteplase - hjerteinfarkt - antithrombotic agents - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Banminth vet 2.2 % w/w Norge - norsk - Statens legemiddelverk

banminth vet 2.2 % w/w

zoetis animal health aps - pyrantelembonat - oralpasta - 2.2 % w/w

Bisoprolol Sandoz 1.25 mg Norge - norsk - Statens legemiddelverk

bisoprolol sandoz 1.25 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 1.25 mg

Bisoprolol Sandoz 2.5 mg Norge - norsk - Statens legemiddelverk

bisoprolol sandoz 2.5 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 2.5 mg

Bisoprolol Sandoz 5 mg Norge - norsk - Statens legemiddelverk

bisoprolol sandoz 5 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 5 mg

Bisoprolol Sandoz 7.5 mg Norge - norsk - Statens legemiddelverk

bisoprolol sandoz 7.5 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 7.5 mg

Bisoprolol Sandoz 10 mg Norge - norsk - Statens legemiddelverk

bisoprolol sandoz 10 mg

sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 10 mg

Isoptin Retard 240 mg Norge - norsk - Statens legemiddelverk

isoptin retard 240 mg

viatris as - verapamilhydroklorid - depottablett - 240 mg

Isoptin Retard 120 mg Norge - norsk - Statens legemiddelverk

isoptin retard 120 mg

viatris as - verapamilhydroklorid - depottablett - 120 mg

Lariam 250 mg Norge - norsk - Statens legemiddelverk

lariam 250 mg

cheplapharm arzneimittel gmbh - meflokinhydroklorid - tablett - 250 mg